Massive Free Documents

Discover millions of professional documents covering academic, business, culture and more.

PRDM16 Regulates Prostate Cancer Cell Dormancy and Prevents Bone Metastatic Outgrowth
PDF

PRDM16 Regulates Prostate Cancer Cell Dormancy and Prevents Bone Metastatic Outgrowth

Added by Emma Wilson
9
A comprehensive study integrating bioinformatics analysis and experimental results on HROB as a potential biomarker for the prognosis of lung adenocarcinoma
PDF

A comprehensive study integrating bioinformatics analysis and experimental results on HROB as a potential biomarker for the prognosis of lung adenocarcinoma

Added by Eliana
8
Epithelial Cell–Specific Prognostic Signature (FTH1, RIT1, WASL, NDRG2, KIFC3) Stratifies Cervical Cancer Patients and Correlates With Immune Infiltration
PDF

Epithelial Cell–Specific Prognostic Signature (FTH1, RIT1, WASL, NDRG2, KIFC3) Stratifies Cervical Cancer Patients and Correlates With Immune Infiltration

Added by Eliana
5
CXCL12 derived from cancer-associated fibroblasts mediates dysfunctional intratumoral adaptive immunity in diabetic pancreatic adenocarcinoma
PDF

CXCL12 derived from cancer-associated fibroblasts mediates dysfunctional intratumoral adaptive immunity in diabetic pancreatic adenocarcinoma

Added by Emma Wilson
5
Biomimetic PD-1 Nanovesicles Inducing Tri-Modal Sonodynamic-Chemo-Immunotherapy for Breast Cancer Therapy and Lung Metastasis Inhibition
PDF

Biomimetic PD-1 Nanovesicles Inducing Tri-Modal Sonodynamic-Chemo-Immunotherapy for Breast Cancer Therapy and Lung Metastasis Inhibition

Added by Eliana
10
Advanced Primary Fallopian Tube Cancer Was Found During Chemotherapy for Multiple Myeloma: A Case Report and Literature
PDF

Advanced Primary Fallopian Tube Cancer Was Found During Chemotherapy for Multiple Myeloma: A Case Report and Literature

Added by Eliana
8
Challenging the extended phenotype - HRD-negative salivary gland carcinoma in a BRCA1 founder-variant carrier - case report and literature review
PDF

Challenging the extended phenotype - HRD-negative salivary gland carcinoma in a BRCA1 founder-variant carrier - case report and literature review

Added by Eliana
9
When cells rebel - a comparative genomics investigation into marsupial cancer susceptibility
PDF

When cells rebel - a comparative genomics investigation into marsupial cancer susceptibility

Added by Eliana
9
The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenocarcinoma
PDF

The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenocarcinoma

Added by Olivia Brown
7
Sarcopenia, myosteatosis and systemic immunoinflammatory index in the prediction of survival in patients undergoing immunotherapy for esophageal cancer
PDF

Sarcopenia, myosteatosis and systemic immunoinflammatory index in the prediction of survival in patients undergoing immunotherapy for esophageal cancer

Added by Eliana
8
Evaluation of quantitative polymerase chain reaction for detecting BRCA1 or BRCA2 copy number loss in high-grade serous ovarian cancer
PDF

Evaluation of quantitative polymerase chain reaction for detecting BRCA1 or BRCA2 copy number loss in high-grade serous ovarian cancer

Added by Emma Wilson
11
EP4 stimulation promotes cell adhesion and migration via IL-6 signaling in oral squamous cell carcinoma
PDF

EP4 stimulation promotes cell adhesion and migration via IL-6 signaling in oral squamous cell carcinoma

Added by Emma Wilson
7
Phosphoglucomutase 5 suppresses gallbladder cancer progression by inhibiting lactate-driven STAT3 signaling
PDF

Phosphoglucomutase 5 suppresses gallbladder cancer progression by inhibiting lactate-driven STAT3 signaling

Added by Emma Wilson
5
Fibroblast activation protein-targeted radiopharmaceuticals: Recent trends in cancer diagnosis
PDF

Fibroblast activation protein-targeted radiopharmaceuticals: Recent trends in cancer diagnosis

Added by Emma Wilson
11
Camizestrant in combination with capivasertib for women with ER-positive, HER2-negative advanced breast cancer: results from SERENA-1
PDF

Camizestrant in combination with capivasertib for women with ER-positive, HER2-negative advanced breast cancer: results from SERENA-1

Added by Emma Wilson
17